Becton, Dickinson and Company

BDX12 Dec 2024
Healthcare
$221.44
0.00 (-0.18%)
Lowest Today
$218.84
Highest Today
$222.93
Today’s Open
$221.44
Prev. Close
$221.44
52 Week High
$245.72
52 Week Low
$216.83
To Invest in Becton, Dickinson and Company

Becton, Dickinson and Company

Healthcare
BDX12 Dec 2024
0.00 (-0.18%)
1M
3M
6M
1Y
5Y
Low
$218.84
Day’s Range
High
$222.93
218.84
52 Week Low
$216.83
52-Week Range
52 Week High
$245.72
216.83
1 Day
-
1 Week
-0.51%
1 month return
-4.38%
3 month return
-6.12%
6 month return
-5.48%
1 Year return
-6.57%
3 Years return
-10.22%
5 Years return
-14.55%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
9.19
BlackRock Inc
7.7
State Street Corp
4.83
T. Rowe Price Associates, Inc.
4.7
Morgan Stanley - Brokerage Accounts
3.8
Vanguard Total Stock Mkt Idx Inv
3.16
T. Rowe Price Investment Management,Inc.
3.08

Market Status

Fundamentals
Market Cap
64023.17 mln
PB Ratio
2.49
PE Ratio
37.72
Enterprise Value
82425.12 mln
Total Assets
57286 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Organisation
Becton, Dickinson and Company
Employees
70000
Industry
Medical Instruments & Supplies
CEO
Mr. Thomas E. Polen Jr.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step